Combination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Lymphocytic Lymphoma

Part of paid clinical trials in Newport Beach, California.

Sponsor
Hoag Memorial Hospital Presbyterian
Study ID
NCT00049413
Phase
PHASE2
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • rituximab — BIOLOGICAL
  • cyclophosphamide — DRUG
  • pentostatin — DRUG

Study Details

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Monoclonal antibodies can locate cancer cells and either kill them or deliver cancer-killing substances to them without harming normal cells. Combining chemotherapy with monoclonal antibody therapy may kill more cancer cells. PURPOSE: Phase II trial to study the effectiveness of combining pentostatin and cyclophosphamide with rituximab in treating patients who have chronic lymphocytic leukemia or lymphocytic lymphoma.

Key Dates

Start date
Jun 30, 2002
Status verified
May 2011
Primary completion
Dec 31, 2004
Completion
Dec 31, 2005

Study Design

Primary purpose
TREATMENT

Locations (1)

FacilityCityStateZIPSite coordinators
Hoag Cancer Center at Hoag Memorial Hospital PresbyterianNewport BeachCalifornia92658-

Find similar trials in Newport Beach, CA

By condition
Leukemia (other)
By specialty
OncologyBlood cancer
By research site
Hoag Cancer Center at Hoag Memorial Hospital Presbyterian· Newport Beach, CA

Related Studies